TR200002273T2 - Hepatit B virüsü (HBV) retroviral ters transkriptaz ve DNA polimeraz inhibe edicilerini içeren antiviraller gibi nükleozidlerin analogları. - Google Patents

Hepatit B virüsü (HBV) retroviral ters transkriptaz ve DNA polimeraz inhibe edicilerini içeren antiviraller gibi nükleozidlerin analogları.

Info

Publication number
TR200002273T2
TR200002273T2 TR2000/02273T TR200002273T TR200002273T2 TR 200002273 T2 TR200002273 T2 TR 200002273T2 TR 2000/02273 T TR2000/02273 T TR 2000/02273T TR 200002273 T TR200002273 T TR 200002273T TR 200002273 T2 TR200002273 T2 TR 200002273T2
Authority
TR
Turkey
Prior art keywords
antivirals
hbv
nucleosides
analogues
hepatitis
Prior art date
Application number
TR2000/02273T
Other languages
English (en)
Inventor
Zhou Xiao-Xiong
Gunnar Johansson Nils
Vahling Horst
Original Assignee
Medivir Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from SE9702957A external-priority patent/SE9702957D0/xx
Priority claimed from SE9704147A external-priority patent/SE9704147D0/xx
Priority claimed from SE9800452A external-priority patent/SE9800452D0/xx
Application filed by Medivir Ab filed Critical Medivir Ab
Publication of TR200002273T2 publication Critical patent/TR200002273T2/tr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/78—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D213/79—Acids; Esters
    • C07D213/80—Acids; Esters in position 3
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/78—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D213/84—Nitriles
    • C07D213/85—Nitriles in position 3
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/04—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C07D307/18—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D307/20—Oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/34—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D307/56—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D307/68—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D473/00—Heterocyclic compounds containing purine ring systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D473/00—Heterocyclic compounds containing purine ring systems
    • C07D473/02—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6
    • C07D473/18—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 one oxygen and one nitrogen atom, e.g. guanine
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D473/00—Heterocyclic compounds containing purine ring systems
    • C07D473/26—Heterocyclic compounds containing purine ring systems with an oxygen, sulphur, or nitrogen atom directly attached in position 2 or 6, but not in both
    • C07D473/32—Nitrogen atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
    • C07D513/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
    • C07D513/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • C07H17/04—Heterocyclic radicals containing only oxygen as ring hetero atoms
    • C07H17/08—Hetero rings containing eight or more ring members, e.g. erythromycins
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/16—Purine radicals
    • C—CHEMISTRY; METALLURGY
    • C40—COMBINATORIAL TECHNOLOGY
    • C40B—COMBINATORIAL CHEMISTRY; LIBRARIES, e.g. CHEMICAL LIBRARIES
    • C40B40/00—Libraries per se, e.g. arrays, mixtures

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Virology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • AIDS & HIV (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Saccharide Compounds (AREA)
  • Peptides Or Proteins (AREA)

Abstract

Bir formül I birlesigidir ki burada, nuc, siklik veya asiklik sakarit yari üzerindeki kendi tekil hidroksi grubu içinden baglanmis olan nükleozid analog kalintisidir, R1, hidroksi, amino veya karboksi arasindan seçilmistir; istege bagli olarak üzerine baglanan esterlesmis/amid, C4-C22 doymus veya doymamis istege bagli olarak sübstitüe olabilen yagli asit veya alkol veya alifatik L-amino asite sahiptir; R2 alifatik L-amino asit kalintisidir; L1 üç-islevli baglayici gruptur; L2 namevcuttur veya iki-islevli bagplayici gruptur; ve bunlarin farmasötik olarak kabul edilebilir tuzlaridir.
TR2000/02273T 1997-08-15 1998-08-14 Hepatit B virüsü (HBV) retroviral ters transkriptaz ve DNA polimeraz inhibe edicilerini içeren antiviraller gibi nükleozidlerin analogları. TR200002273T2 (tr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
SE9702957A SE9702957D0 (sv) 1997-08-15 1997-08-15 Antivirals
SE9704147A SE9704147D0 (sv) 1997-11-12 1997-11-12 Nucleosides
SE9800452A SE9800452D0 (sv) 1998-02-13 1998-02-13 Antivirals

Publications (1)

Publication Number Publication Date
TR200002273T2 true TR200002273T2 (tr) 2002-06-21

Family

ID=27355886

Family Applications (2)

Application Number Title Priority Date Filing Date
TR2000/02273T TR200002273T2 (tr) 1997-08-15 1998-08-14 Hepatit B virüsü (HBV) retroviral ters transkriptaz ve DNA polimeraz inhibe edicilerini içeren antiviraller gibi nükleozidlerin analogları.
TR2000/00398T TR200000398T2 (tr) 1997-08-15 1998-08-14 Hepatit B virüsü (HBV) retroviral ters transkriptaz ve DNA polimeraz inhibe edicilerini içeren antiviraller gibi nükleozidlerin analogları.

Family Applications After (1)

Application Number Title Priority Date Filing Date
TR2000/00398T TR200000398T2 (tr) 1997-08-15 1998-08-14 Hepatit B virüsü (HBV) retroviral ters transkriptaz ve DNA polimeraz inhibe edicilerini içeren antiviraller gibi nükleozidlerin analogları.

Country Status (24)

Country Link
EP (2) EP0988304B1 (tr)
JP (1) JP3844654B2 (tr)
KR (1) KR100529272B1 (tr)
CN (2) CN1130362C (tr)
AT (2) ATE200900T1 (tr)
AU (1) AU728892B2 (tr)
CA (1) CA2298704C (tr)
CZ (1) CZ300757B6 (tr)
DE (3) DE69800753D1 (tr)
DK (1) DK0988304T3 (tr)
ES (2) ES2158689T3 (tr)
GR (1) GR3036004T3 (tr)
HK (2) HK1032968A1 (tr)
HU (1) HU228060B1 (tr)
IL (2) IL134503A0 (tr)
MY (1) MY116269A (tr)
NZ (1) NZ502837A (tr)
PL (1) PL338643A1 (tr)
PT (1) PT988304E (tr)
SG (1) SG96604A1 (tr)
SI (1) SI0988304T1 (tr)
TR (2) TR200002273T2 (tr)
TW (1) TW580500B (tr)
WO (1) WO1999009031A1 (tr)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6458772B1 (en) * 1909-10-07 2002-10-01 Medivir Ab Prodrugs
FR2794752A1 (fr) * 1999-06-11 2000-12-15 Laphal Sa Lab Nouveaux composes derives de nucleosides, leurs procedes de preparation, et les compositions pharmaceutiques en renfermant
FR2796384A1 (fr) * 1999-07-12 2001-01-19 Laphal Sa Lab Nouveaux esters derives de nucleosides, leurs procedes de preparation et les compositions pharmaceutiques en renfermant
MY141789A (en) 2001-01-19 2010-06-30 Lg Chem Investment Ltd Novel acyclic nucleoside phosphonate derivatives, salts thereof and process for the preparation of the same.
AUPS037002A0 (en) * 2002-02-07 2002-02-28 Melbourne Health Viral variants and uses therefor
EP1610781A1 (en) * 2003-03-27 2006-01-04 Boehringer Ingelheim International GmbH Antiviral combination of tipranavir and a further antiretroviral compound
EP1610797A1 (en) * 2003-03-27 2006-01-04 Boehringer Ingelheim International GmbH Antiviral combination of nevirapine and a further antiretroviral compound
EP1610782A1 (en) * 2003-03-27 2006-01-04 Boehringer Ingelheim International GmbH Antiviral combination of a dipyridodiazepinone and a further antiretroviral compound
GB0400290D0 (en) 2004-01-08 2004-02-11 Medivir Ab dUTPase inhibitors
GB0513835D0 (en) 2005-07-07 2005-08-10 Medivir Ab HIV inhibitors
CN103347871A (zh) * 2011-02-21 2013-10-09 美迪维尔公司 Flg的合成
CN113061089A (zh) * 2015-09-23 2021-07-02 凯瑞康宁生物工程（武汉）有限公司 γ-羟基丁酸的前药及其组合物和用途
CN114901657A (zh) * 2019-10-17 2022-08-12 人工智能生物制药公司 抗病毒和肝靶向药物
CN114686188B (zh) * 2020-12-31 2023-05-02 中石化石油工程技术服务有限公司 一种核苷磷脂钻井液润滑剂及其制备方法

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE8602981D0 (sv) * 1986-07-04 1986-07-04 Astra Laekemedel Ab Novel medicinal use
GB8719367D0 (en) * 1987-08-15 1987-09-23 Wellcome Found Therapeutic compounds
WO1989003837A1 (en) * 1987-10-28 1989-05-05 Pro-Neuron, Inc. Acylated uridine and cytidine and uses thereof
JP2788084B2 (ja) * 1988-12-19 1998-08-20 ザ ウエルカム フアウンデーシヨン リミテツド 抗ウイルス化合物
AU663309C (en) * 1991-02-08 2002-08-08 Pro-Neuron, Inc. Oxypurine nucleosides and their congeners, and acyl derivatives thereof, for improvement of hematopoiesis
DE4311801A1 (de) * 1993-04-09 1994-10-13 Hoechst Ag Neue Carbonsäureester von 2-Amino-7-(1,3-dihydroxy-2-propoxymethyl)purin, deren Herstellung sowie deren Verwendung
PE32296A1 (es) * 1994-07-28 1996-08-07 Hoffmann La Roche Ester de l-monovalina derivado de 2-(2-amino-1,6-dihidro-6-oxo-purin-9-il) metoxi-1,3-propandiol y sus sales farmaceuticamente aceptables
WO1997027194A1 (en) * 1996-01-26 1997-07-31 F. Hoffmann-La Roche Ag Process for preparing purine derivatives
US5869493A (en) * 1996-02-16 1999-02-09 Medivir Ab Acyclic nucleoside derivatives
WO1998021223A1 (en) * 1996-11-12 1998-05-22 Medivir Ab Nucleosides

Also Published As

Publication number Publication date
EP0988304B1 (en) 2001-05-02
GR3036004T3 (en) 2001-09-28
EP1123935A3 (en) 2001-09-05
JP2001515079A (ja) 2001-09-18
HUP0100087A3 (en) 2003-01-28
DK0988304T3 (da) 2001-08-20
NZ502837A (en) 2001-01-26
HU228060B1 (en) 2012-09-28
KR20010022873A (ko) 2001-03-26
HUP0100087A1 (hu) 2002-01-28
IL134503A0 (en) 2001-04-30
AU728892B2 (en) 2001-01-18
EP1123935A2 (en) 2001-08-16
DE69800753D1 (de) 2001-06-07
HK1097550A1 (en) 2007-06-29
WO1999009031A1 (en) 1999-02-25
TW580500B (en) 2004-03-21
CN1286845C (zh) 2006-11-29
JP3844654B2 (ja) 2006-11-15
TR200000398T2 (tr) 2000-07-21
CZ300757B6 (cs) 2009-08-05
IL134503A (en) 2010-06-30
CN1275983A (zh) 2000-12-06
MY116269A (en) 2003-12-31
DE69800753T4 (de) 2002-02-21
ES2158689T3 (es) 2001-09-01
PL338643A1 (en) 2000-11-06
SI0988304T1 (en) 2001-08-31
DE69829784T2 (de) 2006-02-16
CA2298704A1 (en) 1999-02-25
CN1130362C (zh) 2003-12-10
ATE293112T1 (de) 2005-04-15
CA2298704C (en) 2006-07-11
HK1032968A1 (en) 2001-08-10
ATE200900T1 (de) 2001-05-15
DE69829784D1 (de) 2005-05-19
DE69800753T2 (de) 2001-10-25
SG96604A1 (en) 2003-06-16
EP0988304A1 (en) 2000-03-29
KR100529272B1 (ko) 2005-11-17
CZ2000449A3 (cs) 2000-08-16
ES2239637T3 (es) 2005-10-01
CN1500800A (zh) 2004-06-02
AU8754898A (en) 1999-03-08
PT988304E (pt) 2001-10-31
EP1123935B1 (en) 2005-04-13

Similar Documents

Publication Publication Date Title
HK1097550A1 (en) Antiviral nucleoside analogues as inhibitors of retroviral reverse transcriptase and dna polymerase
DK0915866T3 (da) Forbedret fremgangsmåde til syntese af beskyttende estere af (S)-3,4-dihydroxysmørsyre
ATE242260T1 (de) Sulfonatfreie cyaninfarbstoffe zur markierung von nukleosiden und nukleotiden
KR930016437A (ko) 올리고뉴클레오티드 유사체, 이의 제조방법 및 용도
TR200100438T2 (tr) Hepatit C inhibitörü peptitler
KR880003974A (ko) 디아민의 선택적 아미딘화 방법
DK0707481T3 (da) L-2',3'-Dideoxy-nucleosidanaloge som anti-hepatitis B (HBV)- og anti-HIV-midler
AU6249501A (en) Nucleotide analogues comprising a reporter moiety and a polymerase enzyme blocking moiety
NZ233197A (en) Aromatically substituted nucleotide derivatives, intermediates therefor and pharmaceutical compositions
DK0777679T3 (da) Indføring af nukleinsyrer
EP1152008A3 (en) Fluorescent nucleotides containing a cyanine, merocyanine or styryl dye for the detection of nucleic acid
KR920700202A (ko) 아크릴로일 치환된 피롤 유도체
ES2166081T3 (es) Derivados de nucleosidos con grupos protectores fotolabiles.
Kimura et al. A new class of anti-HIV agents: synthesis and activity of conjugates of HIV protease inhibitors with a reverse transcriptase inhibitor
ATE339434T1 (de) Basenanaloge
EP1057825A4 (en) ISOFLAVANE DERIVATIVES AND IMMUNOSTIMULATING COMPOSITIONS CONTAINING THEM
AU7653300A (en) Carbocyclic nucleosides and process for obtaining such
BR9706795A (pt) Método melhorado para a determinação de lipase
JPS5441891A (en) Adenine nucleotide derivative
EP0331756A4 (en) Agents for prophylaxis and treatment of thrombopenia
DK0912751T3 (da) Fremgangsmåde til fremstilling af D-prolinderivater ved hjælp mikroorganismer
BR0107864A (pt) ésteres de ácidos graxos e álcoois juvenóides, e método para preparação e uso dos mesmos